InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,244.80
(
1.57%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.00%
)
Bitcoin
63,672.96
(
0.41%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bra1loga

Send PM Follow Ignore
Followers 385
Posts 8154
Boards Moderated 7
Alias Born 07/15/2007

bra1loga

Re: None

Friday, 09/19/2014 2:57:25 PM

Friday, September 19, 2014 2:57:25 PM

Post# of 97237
OPK - September 20, 2014 in Dublin, Ireland OPKO will present six month efficacy, safety, pharmacokinetic and pharmacodynamics data from the company’s advanced phase 2 trial for its long acting human growth hormone hGH-CTP (MOD-4023) in growth hormone deficient pediatric subjects.

Exchange Personmarks?

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up